Oaktree Acquisition Corp. III Life Sciences
For the period ended Dec 31, 2024. Filed Mar 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 27, 2025
OACC$10.70-0.2%Stored close · as of Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statement of Cash Flows
| Cash Flows from Operating Activities: | |
|---|---|
| Net income | $1,331,707 |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Interest earned on cash held in Trust Account | (1,588,732) |
| Change in fair value of overallotment liability | (94,781) |
| Payment of operation costs through promissory note | 41,160 |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | (201,281) |
| Long-Term prepaid insurance | (113,275) |
| Accounts payable and accrued expenses | 535,515 |
| Net cash used in operating activities | (89,687) |
| Cash Flows from Investing Activities: | |
| Investment of cash in Trust Account | (191,990,290) |
| Net cash used in investing activities | (191,990,290) |
| Cash Flows from Financing Activities: | |
| Proceeds from sale of Units, net of underwriting discounts paid | 188,148,351 |
| Proceeds from sale of Private Placement Units | 5,839,810 |
| Repayment of promissory note - related party | (551,140) |
| Net cash provided by financing activities | 193,437,021 |
| Net Change in Cash | 1,357,044 |
| Cash – Beginning | — |
| Cash – Ending | $1,357,044 |
| Non-cash investing and financing activities: | |
| Offering costs included in accrued offering costs | $179,984 |
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | $25,000 |
| Deferred offering costs paid through promissory note – related party | $128,893 |
| Prepaid services contributed by Sponsor through promissory note - related party | $392,910 |
| Deferred underwriting fee payable | $6,719,660 |
| Deferred legal fee payable | $299,088 |
| Forfeiture of Founder Shares | $23 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.